Literature DB >> 21380509

Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks.

Patrizia Bernini1, Ivano Bertini, Claudio Luchinat, Paola Nincheri, Samuele Staderini, Paola Turano.   

Abstract

(1)H NMR metabolic profiling of urine, serum and plasma has been used to monitor the impact of the pre-analytical steps on the sample quality and stability in order to propose standard operating procedures (SOPs) for deposition in biobanks. We analyzed the quality of serum and plasma samples as a function of the elapsed time (t = 0-4 h) between blood collection and processing and of the time from processing to freezing (up to 24 h). The stability of the urine metabolic profile over time (up to 24 h) at various storage temperatures was monitored as a function of the different pre-analytical treatments like pre-storage centrifugation, filtration, and addition of the bacteriostatic preservative sodium azide. Appreciable changes in the profiles, reflecting changes in the concentration of a number of metabolites, were detected and discussed in terms of chemical and enzymatic reactions for both blood and urine samples. Appropriate procedures for blood derivatives collection and urine preservation/storage that allow maintaining as much as possible the original metabolic profile of the fresh samples emerge, and are proposed as SOPs for biobanking.

Entities:  

Mesh:

Year:  2011        PMID: 21380509     DOI: 10.1007/s10858-011-9489-1

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  39 in total

1.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics.

Authors:  Joanne T Brindle; Henrik Antti; Elaine Holmes; George Tranter; Jeremy K Nicholson; Hugh W L Bethell; Sarah Clarke; Peter M Schofield; Elaine McKilligin; David E Mosedale; David J Grainger
Journal:  Nat Med       Date:  2002-11-25       Impact factor: 53.440

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  Metabolomics: available results, current research projects in breast cancer, and future applications.

Authors:  Wederson Marcos Claudino; Alessandro Quattrone; Laura Biganzoli; Marta Pestrin; Ivano Bertini; Angelo Di Leo
Journal:  J Clin Oncol       Date:  2007-05-14       Impact factor: 44.544

4.  UK Biobank Pilot Study: stability of haematological and clinical chemistry analytes.

Authors:  Chris Jackson; Nicky Best; Paul Elliott
Journal:  Int J Epidemiol       Date:  2008-04       Impact factor: 7.196

5.  The UK Biobank sample handling and storage validation studies.

Authors:  Tim C Peakman; Paul Elliott
Journal:  Int J Epidemiol       Date:  2008-04       Impact factor: 7.196

6.  1H NMR investigations of the molecular nature of low-molecular-mass calcium ions in biofluids.

Authors:  Christopher L Silwood; Martin Grootveld; Edward Lynch
Journal:  J Biol Inorg Chem       Date:  2001-07-19       Impact factor: 3.358

7.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease.

Authors:  Julian R Marchesi; Elaine Holmes; Fatima Khan; Sunil Kochhar; Pauline Scanlan; Fergus Shanahan; Ian D Wilson; Yulan Wang
Journal:  J Proteome Res       Date:  2007-02       Impact factor: 4.466

8.  Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.

Authors:  Friederike Teichert; Richard D Verschoyle; Peter Greaves; Richard E Edwards; Orla Teahan; Donald J L Jones; Ian D Wilson; Peter B Farmer; William P Steward; Timothy W Gant; Andreas J Gescher; Hector C Keun
Journal:  Prostate       Date:  2008-07-01       Impact factor: 4.104

9.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

10.  Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice.

Authors:  Jane F Fearnside; Marc-Emmanuel Dumas; Alice R Rothwell; Steven P Wilder; Olivier Cloarec; Ayo Toye; Christine Blancher; Elaine Holmes; Roger Tatoud; Richard H Barton; James Scott; Jeremy K Nicholson; Dominique Gauguier
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

View more
  79 in total

1.  Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks.

Authors:  Ophélie Fliniaux; Gwenaelle Gaillard; Antoine Lion; Dominique Cailleu; François Mesnard; Fotini Betsou
Journal:  J Biomol NMR       Date:  2011-10-02       Impact factor: 2.835

2.  Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population.

Authors:  Christopher D Hart; Alessia Vignoli; Leonardo Tenori; Gemma Leonora Uy; Ta Van To; Clement Adebamowo; Syed Mozammel Hossain; Laura Biganzoli; Emanuela Risi; Richard R Love; Claudio Luchinat; Angelo Di Leo
Journal:  Clin Cancer Res       Date:  2017-01-12       Impact factor: 12.531

3.  Emerging Biomarkers of Illness Severity: Urinary Metabolites Associated with Sepsis and Necrotizing Methicillin-Resistant Staphylococcus aureus Pneumonia.

Authors:  Lilliam Ambroggio; Todd A Florin; Samir S Shah; Richard Ruddy; Larisa Yeomans; Julie Trexel; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2017-07-28       Impact factor: 4.705

4.  A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase.

Authors:  Maximilian Bielohuby; Sarah Popp; Martin Bidlingmaier
Journal:  Mol Metab       Date:  2012-08-09       Impact factor: 7.422

5.  Application of NMR spectroscopy in metabolomics.

Authors:  Brian D Sykes
Journal:  J Biomol NMR       Date:  2011-04       Impact factor: 2.835

6.  Reproducibility of non-fasting plasma metabolomics measurements across processing delays.

Authors:  Ying Wang; Brian D Carter; Susan M Gapstur; Marjorie L McCullough; Mia M Gaudet; Victoria L Stevens
Journal:  Metabolomics       Date:  2018-09-25       Impact factor: 4.290

7.  Impact of post-collection freezing delay on the reliability of serum metabolomics in samples reflecting the California mid-term pregnancy biobank.

Authors:  Michael R La Frano; Suzan L Carmichael; Chen Ma; Macy Hardley; Tong Shen; Ron Wong; Lorenzo Rosales; Kamil Borkowski; Theresa L Pedersen; Gary M Shaw; David K Stevenson; Oliver Fiehn; John W Newman
Journal:  Metabolomics       Date:  2018-11-15       Impact factor: 4.290

8.  Citrate NMR peak irreproducibility in blood samples after reacquisition of spectra.

Authors:  Munsoor A Hanifa; Raluca G Maltesen; Bodil S Rasmussen; Katrine B Buggeskov; Hanne B Ravn; Martin Skott; Søren Nielsen; Jørgen Frøkiær; Troels Ring; Reinhard Wimmer
Journal:  Metabolomics       Date:  2019-12-19       Impact factor: 4.290

Review 9.  Biobanking for research in surgery: are surgeons in charge for advancing translational research or mere assistants in biomaterial and data preservation?

Authors:  Wolfgang E Thasler; Reinhard M K Thasler; Celine Schelcher; Karl-Walter Jauch
Journal:  Langenbecks Arch Surg       Date:  2013-02-22       Impact factor: 3.445

10.  Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing.

Authors:  Kedir N Turi; Lindsey Romick-Rosendale; Tebeb Gebretsadik; Miki Watanabe; Steven Brunwasser; Larry J Anderson; Martin L Moore; Emma K Larkin; Ray Stokes Peebles; Tina V Hartert
Journal:  Metabolomics       Date:  2018-10-01       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.